drugset / Trial / NCT01530451
Clinical Trial of Desmopressin on Nocturia in Obstructive Sleep Apnoea Patients
RandomizedCrossoverTriple-blindTreatment
Summary
The purpose of the study is to evaluate the efficacy of desmopressin on symptoms of nocturia in patients with Obstructive Sleep Apnoea (OSA). The improvement of sleep quality and the quality of life will be measured.
Timeline
- Start
- 2012-03
- Primary completion
- 2015-02
- Completion
- 2015-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Desmopressin | Peptide | 120 mg | — |